AEM.T 35.49 (+0.15 | +0.42%) AEM 35.63 (+0.13 | +0.37%) FM.T 21.83 (+0.05 | +0.23%) SLW.T 35.56 (-0.21 | -0.59%) SLW 35.66 (-0.27 | -0.75%) YRI.T 16.40 (-0.20 | -1.20%) AUY 16.46 (-0.16 | -0.96%) HBM.T 12.07 (+0.14 | +1.17%) HBM 12.15 (+0.18 | +1.50%) MDI.T 16.93 (+0.08 | +0.47%) WIN.T 5.56 (+0.07 | +1.28%) WILN 5.60 (+0.08 | +1.45%) TCM.T 9.20 (-0.09 | -0.97%) TC 9.21 (-0.13 | -1.39%) TH.T 2.32 (+0.06 | +2.65%) THER 2.31 (+0.05 | +2.21%) OSK.T 11.56 (0.00 | 0.00%) CG.T 19.07 (+0.17 | +0.90%) CDM.T 27.67 (-0.45 | -1.60%) CDE 27.79 (-0.46 | -1.63%) CSI.T 6.91 (-0.09 | -1.29%) TXG.T 2.12 (+0.08 | +3.92%) MT.T 11.20 (+0.21 | +1.91%) ST.T 0.79 (0.00 | 0.00%) MGT.T 2.03 (-0.06 | -2.87%) MGN 2.02 (-0.08 | -3.81%) CZO.V 0.09 (+0.01 | +6.25%) AHF.T 1.58 (+0.04 | +2.60%) NIF.UN.T 6.05 (+0.01 | +0.17%) LOR.T 0.22 (+0.01 | +2.33%) SSP.V 1.30 (-0.01 | -0.76%) PML.V 0.66 (+0.02 | +3.13%) ATM.V 4.10 (0.00 | 0.00%) MMS.T 1.13 (+0.12 | +11.88%) MMSDF.O 1.10 (+0.08 | +7.84%) RVM.T 4.59 (-0.11 | -2.34%) RVM 4.58 (-0.12 | -2.55%) DHX.T 0.97 (+0.04 | +4.30%) RNX.T 0.69 (0.00 | 0.00%) GTP.V 0.50 (-0.02 | -3.85%) COLTF.O 0.48 (0.00 | 0.00%) WOF.V 0.25 (+0.01 | +4.17%) WFEMF.O 0.23 (0.00 | 0.00%) CLQ.T 0.70 (+0.05 | +7.69%) CLQMF.O 0.68 (+0.03 | +4.62%) SBL.V 0.19 (0.00 | 0.00%) BOZ.V 0.53 (0.00 | 0.00%) R.T 1.17 (+0.01 | +0.86%) EMD.T 0.19 (+0.01 | +2.78%) CSQ.V 0.13 (-0.01 | -3.70%) FPX.V 0.66 (-0.04 | -5.71%) MRY.T 0.16 (0.00 | 0.00%) CEG.T 0.57 (-0.01 | -1.72%) CEGMF.O 0.50 (-0.12 | -18.92%) NFR.V 0.30 (+0.02 | +5.36%) NFRGF.O 0.31 (+0.01 | +4.42%) LAC.T 1.31 (-0.09 | -6.43%) LHMAF.O 1.43 (0.00 | 0.00%) FT.T 1.00 (0.00 | 0.00%) CAL.T 0.12 (0.00 | 0.00%) CALVF.O 0.13 (+0.01 | +12.61%) CRK.T 0.58 (-0.01 | -1.69%) CROCF.O 0.58 (-0.01 | -1.70%) AVR.T 1.51 (0.00 | 0.00%) AVGCF.O 1.51 (-0.02 | -1.49%) BMC.V 0.08 (-0.01 | -11.76%) MON.V 0.21 (0.00 | 0.00%) AAB.T 0.61 (-0.01 | -1.61%) SUE.T 1.52 (-0.01 | -0.65%) SDDDF.O 1.57 (+0.03 | +2.05%) EE.T 1.83 (+0.05 | +2.81%) APE.V 0.18 (0.00 | 0.00%) BCU.V 0.08 (0.00 | 0.00%) MIN.V 0.83 (+0.08 | +10.67%) EXMGF.O 0.85 (+0.06 | +7.35%) LMA.T 3.25 (+0.01 | +0.31%) LDI.V 0.16 (+0.01 | +3.23%) HRT.T 0.20 (-0.01 | -2.44%) CT.V 0.10 (0.00 | 0.00%) CTIIF.O 0.10 (+0.03 | +34.49%) AMC.T 0.05 (+0.01 | +11.11%) AXSMF.O 0.06 (+0.01 | +31.76%) SDI.T 0.24 (-0.01 | -4.00%) DIAGF.O 0.24 (0.00 | 0.00%) GMX.T 1.32 (0.00 | 0.00%) GLBXF.O 1.37 (0.00 | 0.00%) MWC.V 0.11 (0.00 | 0.00%) AAST.O 0.06 (-0.02 | -25.00%) GWA.V 0.19 (+0.01 | +2.70%) MDG.T 0.61 (+0.01 | +1.67%) PSD.T 1.70 (0.00 | 0.00%)

Medwell Capital Corp.

MWC.V (TSX Venture)
$0.11aaa
Change 0.00 0.00%
Volume 0
52 week Low Hi
  $0.09 $0.29
Financial Information
Shares Outstanding: 91,008,923
(As per the latest financial statements)
Fully Diluted Shares: 103,481,548
(As per management)
Est. Market Float: -
Market Cap.: $9,555,937
EPS last 3 months : $(0.14)
EPS Trailing 12 months: $(0.09)
Long-Term Debt: -
Financial Year-End: Dec 31
Updated: 2012-02-09 17:20
15-20 minutes delay

Renmark Financial Disclaimer

The information contained above was approved by the company presented and is reproduced with its authorization. The accuracy and completeness of that information are the sole responsibility of the said company.

This document is published for general information only and it should not be interpreted as an investment recommendation nor an offer or a solicitation to buy or sell securities issued by the said company. Renmark does not and will not accept any responsibility or liability for investment decisions made on the basis of the information herein contained.

Medwell Capital Corp. (formally named BioMS Medical Corp.) is a Canadian-based service provider in the healthcare industry, whereby Medwell Capital directly invests in and advises companies on strategy, financing, mergers & acquisitions (M&A), and licensing transactions and undertakes technology development.

Medwell Capital prides itself with an experienced scientific, clinical and business development team, the strategic and financial network of its partners, and the close relationships developed with numerous healthcare companies and management.

Kevin Giese, President & Chief Executive Officer

Brent Johnston, Chief Financial Officer

Tony Hesby, Executive Vice-President

Richard Brown, Vice-President, Commercial Development

Dr. Tony Verco, Vice-President, Drug Development

Randy Stroud, Vice-President, Regulatory Affairs

Ryan Giese, Vice-President, Corporate Communications

Clifford Giese, Chairman

Kevin Giese, Director

Laine Wollard, Director

Dr. John Wetherell, Director

William D. Grace, Director

Gordon Politeski, Director

Headquarters:

8812 - 60 Avenue
Edmonton, Alberta
T6E 6A6 Canada

Telephone: (780) 413-7152
Fax: (780) 408-3040

For additional info., contact
Christine Stewart
Peter Mahzari

Montréal

Telephone: (514) 939-3989
Fax: (514) 939-3717

Toronto

Telephone: (416) 644-2020
Fax: (416) 644-2021
Home Medwell Capital Corp.